VIVIMEDLAB — Vivimed Labs Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
Annual cashflow statement for Vivimed Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -758 | -643 | -3,307 | -458 | -315 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 539 | 398 | 359 | 24.3 | 29.5 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5,337 | 338 | 2,117 | -5.41 | 65.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 5,673 | 275 | 254 | -240 | -17.5 |
| Capital Expenditures | — | -164 | — | -20.4 | -45.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 4,040 | 0 | 49.7 | 303 | — |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | 4,040 | -164 | 49.7 | 283 | -45.3 |
| Financing Cash Flow Items | -539 | -398 | -359 | -24.3 | -29.5 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -10,153 | -104 | -338 | -60.3 | 49.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -441 | 7.53 | -34.2 | -17.4 | -13.2 |